Page 1

THE CVAA

Newsletter of the Canadian Vascular Access Association

Fall 2017

Meet the Board — Carmen Cernusca Why did you join the CVAA Board? I was very interested in promoting best practice in vascular access as, at that time, I had come into contact with a lot of differing practices. I had done much research, as I entered into the role of the vascular access educator and wanted to learn from the expertise of a team that spanned Canada. I was already involved with the GDG and knew that there was a great team already in place and I wanted to continue to learn from them and with them.

What are you the most excited about for 2018 with CVAA? Completion and dissemination of the national guidelines! What aspect of the past conference did you enjoy the most? Or what do you look forward for next year?  The past conference was the first time I had been actively involved in its production. It was great to see all of the attendees networking and learning about practices that they could take back home with them to improve their organizations’ practices.

Tell us something interesting about yourself (personal, not professional) I have been married for nine years to my wonderful husband Mike and we have two daughters Aryana (7) and Calleigh (5).

May 29, 2017 Greater Hamilton CVAA Chapter event Aman Sohi (CHS), Norica Stein (Hamilton Health Sciences), Connie Wootten (Greater Hamilton Chapter), Karen Kelln (SterileCare Inc.)


Cook Medical: Providing decades of vascular access innovation and leadership.

Retirement announcement: Sharon Armes, RN, CVAA(C) Those of you who have been a part of CVAA for many years will surely know Sharon Armes. Sharon has been with CVAA since the beginning and has been a constant support throughout the years. She is a former Board member and a Lifetime Member, as well. Sharon is a graduate of St. Joseph’s Hamilton in 1972. Her career has focused primarily on vascular access—first as an IV Nurse and then as the Central Venous Access Nurse at McMaster. It is here that she became the second nurse in Canada to insert PICCs. She assumed a role with Bard Canada as Clinical Resource in 1999 and provided resource nationally. In 2011, she was promoted to the International Division of Bard. Initially, her territory covered China, Pan-Asia and Latin America. During the following two years she divided her time between Russia, Turkey, Eastern Europe, North Africa, the Middle East and Latin America. She was a member of the International Team for Bard focusing on specific countries annually. She is a member of CVAA, AVA, INS and WoCoVA. She has participated on many boards and panels including four years on the CVAA Board. She has also been honoured with an Honorary Life Membership for CVAA, as well as the Barbara Hill Award. She was also honoured in her workplace, as a recipient of the Charles Russell Bard award. Her passion remains improving patient outcomes and sharing information with her colleagues.

SPECTRUM

PROCESS BUNDLE

T EC HNOLOGY

Rely on Cook Medical for the vascular access tools you need to provide evidence-based patient care. Learn how Cook Spectrum® technology meets the CDC’s 1A recommendation1 as a component of the prevention of central line-associated bloodstream infections (CLABSIs) and lowers the risk for catheterrelated bloodstream infections (CRBSIs)2 at cookmedical.com/spectrum.

Please join us as we thank Sharon for her dedication to CVAA and wish her all the best in retirement!

Fall 2017 | Page 3

1. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Centers for Disease Control and Prevention website. www.cdc.gov/infection control/pdf/guidelines/bsi-guidelines.pdf. Updated February 15, 2017. Accessed July 17, 2017. The 1A recommendation from the Centers for Disease Control and Prevention (CDC) is to “use a chlorhexidine/silver sulfadiazine or minocycline/rifampin -impregnated CVC in patients whose catheter is expected to remain in place >5 days if, after successful implementation of a comprehensive strategy to reduce rates of CLABSI, the CLABSI rate is not decreasing.”

MEDICAL

2. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med. 1997;127(4):267-274.

© COOK 08/2017

CC-D36824-EN-F


Join the 2018 Board of Directors This is an extraordinary opportunity for individuals who are passionate about CVAA’s mission and are interested in leadership, affecting change and furthering the association. Several positions are available at this time and all CVAA members are invited to apply. Board of Directors positions each carry a two (2)-year term. The available positions for 2018-2019 are: • One President-Elect 2018 (President 2019 & 2020, Past President 2021) • Two Directors-At-Large (2018 & 2019) • One Industry Representative (2018 & 2019) Expectations for ALL directors are in the Governance Manual here.

Ideal candidates will have the following qualifications: • understand and demonstrate a commitment to CVAA, our mission and our programs • keep up to date with issues and trends that affect the organization • prepare for meetings by reading agendas, minutes, reports and other documentation required to actively participate in them  • contribute skills and knowledge by participating actively in meetings and committee work • work collaboratively as a team  • personal qualities of integrity, credibility, and a passion for improving the practice of vascular access/infusion therapy.

Fall 2017 | Page 4

President-Elect/President (See the full role description here) In addition to the expectations of the Directors-At-Large below, some key points for the President-Elect/President include: • the skill and ability to act as a CVAA spokesperson and ambassador • will participate and lead (as President) meetings and activities of the Board Executive • lead monthly Board meetings • liaise regularly with the Executive Director on all association matters • take the significant leadership role with the Board and the association.

continued on page 6…


…continued from page 4 Directors-At-Large (See the full role description here) Some key points and expectations for Directors-AtLarge for the 2018–2019 term: • are CVAA(C) certified or obtain the certification within first year of their term • participate in monthly Board meetings by teleconference • participate in other meetings and activities called by the president for various issues, as required • attend the CVAA national conference, April 24–27, 2018 in Toronto, ON • attend an in-person meeting in Toronto, ON (weekend in early February 2018 – exact dates to be confirmed). Industry Representative (See the full role description here) Some key points and expectations for the Industry Representative for the 2018– 2019 term:

• industry representatives are not required to be CVAA(C) certified, however, are welcome and encouraged to do so • participate in monthly Board meetings by teleconference • participate in other meetings and activities called by the President for various issues, as required • attend the CVAA national conference, April 24–27, 2018 in Toronto, ON • attend an in-person meeting in Toronto, ON (weekend in early February 2018 – exact dates to be confirmed). Service on the CVAA Board of Directors is without remuneration, except for administrative support, travel, and accommodation costs in relation to duties. For industry reps, all costs of participation as a Board member shall be covered by your employer.

This year, CVAA will hold staggered elections. The first shall be for the President-Elect position (week of November 13–17) and the second for Directors-At-Large and Industry Rep positions (week of November 20–24). If you put your name forth for the President-Elect election, you will have the option to let your name stand for the DirectorsAt-Large position in the second election if you are unsuccessful in the first election. Nominations are due by November 10, 2017, at 4:00 pm EST and must be submitted through the CVAA website here. Voting by electronic vote will be open during the month of November 2017.  Please contact cvaa@cvaa.info with any questions. We hope you will consider submitting your nomination to be a part of the CVAA National Board of Directors!

SUBMIT YOUR NAME HERE

Fall 2017 | Page 6


NEOCVAA’S 6th Annual Education Day: Meeting Vascular Access Challenges Our 6th annual CLE took place on September 25, 2017, at the Steelworkers Hall in Sudbury, ON. More than 95 participants were present for this well-attended education day, from Cochrane in the north to London in the south and many cities in between. We also had eight booths manned by industry experts who were very eager to share their knowledge about their products. NEOCVAA is very grateful to all sponsors for helping to make our conference a great success. These included reps from Baxter, 3M, BARD, BD, CardioMed Supplies, Cook Medical, Smiths Medical, and BBraun. Our four guest speakers shared their expertise on peripheral and central venous therapy, looking at potential problems and solutions, as well as new developments in IV therapy. Dr. Michael Schmidt discussed possible complications that can arise when central lines are inserted in the DI department and how to deal with

these issues. Bonnie Onyschuk, RN (BD Clinical Specialist), shared her expertise on peripheral intravenous devices, focusing on best practices and current standards using the Infusion Therapy Standards of Practice (INS) 2016. Sarah Smees, RN (BARD Clinical Specialist), outlined potential complications associated with CVADs, including air embolism, catheter occlusion, infection, catheter-associated thrombosis, pneumothorax and catheter tip malposition to name but a few. Emphasis was placed on using strict aseptic technique and ultrasound technology during insertion of CVADs to greatly reduce complications. Our final speaker was Sheryl McDiarmid, RN, APN in Central Vascular Access and Apheresis Programs at the Ottawa Hospital, and current CVAA National President. Her presentation was thought-provoking, focusing on lymphedema and how it impacts vascular access

Fall 2017 | Page 8


in survivors of breast cancer, in particular. By providing a great review of the lymphatic system and identifying who is at risk of developing lymphedema she highlighted the need to overcome myths while making evidence-based, informed decisions related to vascular access in these patients.

Congratulations to our NEOCVAA board for once again organizing an amazing education day, providing us with new information to share with colleagues and a great opportunity to network with peers and experts alike. Lise Paquette, BScN, RN, CVAA(C), CON(c) NEO CVAA Chapter

Once again, we had the pleasure of finishing our day by taking part in skills stations allowing us to interact with experts and apply hands-on techniques. It was difficult for many to choose only four skills lab stations since the various topics were current, interesting and practicerelated. Subjects covered included no-touch PICC dressing technique; documentation of peripheral IV and best practice; pH and risk of tissue damage from commonly given medications; troubleshooting central lines; port accessing/ flushing; distinguishing between positive, negative and neutral displacement devices; best practice techniques for blood collection; and CVAD dressing application.

Fall 2017 | Page 9


CALL FOR ABSTRACTS Plenary, Concurrent, Skills Lab and Poster Presentations 43rd Annual CVAA Conference | April 25–27, 2018 Educate, Engage & Empower: Advancing a Broader Vision for Canadian Infusion Therapy The 2018 CVAA Conference Committee invites you to submit an abstract for your plenary, concurrent, Skills Lab round-table demonstration or poster presentation at the 43rd Annual CVAA Conference.  How to Submit Complete the online forms below. All proposals must be submitted online. Proposals submitted by fax or mail will not be accepted. Please present enough details to evaluate the presentation; failure to do so adequately may result in rejection. Describe or outline topics presented, with enough detail for reviewers to fully understand the content proposed and the presentation strategies. Schedule September 8, 2017 November 3, 2017 December 8, 2017 December 15, 2017 January 12, 2017

Call for Abstracts open Submission deadline for abstracts 4:00 pm EST Acceptance or rejection notification for all submissions Presenter acceptance deadline Preliminary program available

All applications must be received no later than 4:00 pm EST, Friday, November 3, 2017. Submit here

Fall 2017 | Page 10


Fall 2017 | Page 11


Continuing Education Questions Fall 2017 1. Where is the best place to begin assessing for site selection for routine therapy? a) The most prominent vein b) The dominant side, despite patient’s wishes c) The antecubital fossa d) The dorsal metacarpal veins

4. Frequent site monitoring is required for geriatric patients due to: a) Decreased peripheral sensation b) Lethargy c) Fluid deficit d) None of the above

2. What are the signs of catheter occlusions? a) Sluggish infusion of medication or fluid b) Inability to aspirate blood c) Inability to infuse a medication or fluid d) All of the above

5. The catheter-skin junction (insertion) site should be inspected and assessed daily for: a) Tenderness, drainage, intact dressing b) Drainage c) Evidence of occlusion d) None of the above

3. Balanced electrolyte solutions are recommended for use in patients except for: a) Trauma b) Sodium depletion c) Burns d) Rapid weight loss

6. Quality improvement activities often involve monitoring the outcomes directly related to clinician intervention. In infusion therapy, an outcome that may be monitored includes: a) Needlestick injuries experienced by newly diagnosed diabetics b) Falls risk related to the use of infusion pumps c) CLABSI (central line associated blood stream infections) in the ICU d) Venous thromboembolism prevention in surgical patients

Answers to Issue 2 (Summer) CVAA Link questions: 1. B; 2. C; 3. B; 4. B; 5. D; 6. C

Fall 2017 | Page 12


CVAA Certified Members Directory / Épertoire des membres certifiés We are pleased to promote and celebrate our CVAA members who have successfully passed the CVAA(C) Certification Exam. The directory includes only the names of those members who chose to have their name published. If you are certified and want to be in the directory, email Melissa McQueen at cvaa@cvaa.info. Nous sommes heureux de promouvoir et de célébrer le succès des membres de l’ACAV qui ont réussi l’examen de certification. Le répertoire ne contient que les noms des membres qui ont choisi d’y figurer. Si vous êtes certifié et souhaitez être dans le répertoire, envoyez un courriel à Melissa McQueen à cvaa@cvaa.info. Remember, if your certification is up for renewal December 31, 2017, visit here to learn more about logging your points in the online score sheet and the recertification process today! Tannia Agnot-Johnston Wanita Akerberg Willard Amper Sheldon Appell Sharon Armes Sarah Armitage Glenda Armitage Cheryl Arsenault Madeleine Ashcroft Sherry Balbon Janet Barr Angeles Bell Rita Bergsma Sylvie Bernard Andrea Berseth (nee Sunderman) Julie Bilbrey Isobelle Blake Christine Bogle Jennifer Bourne

Karen Bowers Kim Bowness Kim Boyd Rebecca Brisebois Daphne Broadhurst Donna Brooks Alice Brown Barbara Brown Evelyn Brown Donna Burkart Kristine Byrne Joanne Campbell Angele Caporicci Pat Carlson Kristine Carrillo Dawne Carroll Carmen Cernusca Sandra Cerutti Jennifer Cham Annie Chaput

Fall 2017 | Page 13

Kimberly Charlong Glen Chenard Kerri Clarkson Nan Cleator Kristyn Cole Jennifer Colvine Cheryl Cook Diane Cooper Kaydin Crane Tiffany Crisp Joy Dacquisto Michelle DaGloria Chantel Daignault Erin Davidson Christine deBoer Kristine Desjardine Marcie Desrosiers Kimberlei Dool Sandra Dragic Jody Dumanski Linda Dunlop Samantha Ellison-Nash Pamela Elwood Serena Engler Jodie Errington Ola Esho


Sandra Filopoulos Shirley Fisher Virginia Fleming Jacinthe Forget Shirley Francis Audrey Fraser Nancy Friesen Alberto Galase Krista Getson Laura Giannantonio Dawn Gibbons Joyce Giesbrecht Mary-Ann Glasier Wendy Goldman Cynthia Grosse Christine Guerin Nicole Guy Tracey Hagan-O’Connor Jennifer Hall Julie Hamill

Kelly Hand Elizabeth Hangya Dianne Harding Geneva Hiebert Ann Higgins Sandra Hlina Barbara Hodgson Mija Hong Valrie Hursefield Carol Huston Cathie Hutfluss Linda Ingalls Anne Jackson Tami Jemson Caroline Jenner Erikka Johnson Sherri Keller Karen Kelln Linda Kells Linda-Anne Klassen

Fall 2017 | Page 14

Darlene Klassen Mary Beth Kornacki Sylvie Kozlowskyj Rupali Krishna Barb Kuehrig Ursula Kuisma Deborah Labelle Shelley Lacelle Karen Laforet Cathryn Laing Beth Lambert Lynne Larose Ashley LaRose Shannon Laspa Linda Lawson Minh Le Sandra Lemphers Francis Schweitzer Liao Jing Lin Mary Lloyd


Renee Logan Jayne Lowenberg Kerin Lubbe Vincent Lucifora Dara Macht Fiona Mackintosh Kaitlin MacPhail Heather MacQuarrie Joan Maguire Justina Mah Karen Mallet Cherylanne Margherit Deb Marshall (nee Hanson) Fay Martens AndrĂŠ Martin Tracey Martin Sharron Maskevich Laurie Matthies Meadow McClintock Sheryl McDiarmid Marie McDonnell Natalie McGann Rosemary Miles Veronica Miller Anita Moench Denise Morbin Debbie Morgan Sherri Morrish Sukaina Muhammad Jennifer Murphy-Novak Kristie Naayer Kelly-Lynn Nancekivell Susanne Nelson Kim Newcombe Shannon Nugent Cheryl Lynne Nyman Jonathan Osagiede Audrey Oudkerk Cheryl Page France Paquet Lise Paquette Linda Parton Celeste Pass

Kathy Patterson Diana Pearson Kelly Peloso Marina Pereira Sharlean Phillips Jolanta Piatek Alison Pinette

Fall 2017 | Page 15

Cherie Pinkerton Linda Pittendreigh Jeff Poirier Laura Pope-Goulet Carole Pugle Jessica Purjue Pavnique Randhawa


Leanne Rathbun Andrea Raynak Lorminia Realeza Joanna Rechberger Andrea Redman Charity Reeves Janet Reid Karen Reid Anne Robinson Sharon Rodkin Katherine Ross Steve Roy Kelly Sabara Tami Sandrelli Lisa Sangster Cathy Santa Maria April Savard Alice Colleen Saydak

Geraldine Schaack Tara Schmitz Forsyth Doris Schoeni Dana Scott Christine Seewald Teresa Seward Valorie Shaddick Gillian Shane Abha Sharma Jo Ann Shephard Allison Sheridan Karin Silva Lynn Slota Laurie Snook Ruth Souter Lin Stevenson Karen Swan Amera Taylor

Fall 2017 | Page 16

Debra Theriault Penny Thievin Michelle Thomas Jo Ann Tighe Kathleen Toth Marla Townshend Annie Villeneuve Elaine Walker Lisa Warden Belinda Waylett Cara Wetherill Dorothea Wicklund Susanne Wiebenga Elizabeth Wilcox Quincy Sylvester Williams Adam Wires Erin Zackowski Grace Zwart


The CVAA Link: Fall 2017  
The CVAA Link: Fall 2017  

Newsletter of the Canadian Vascular Access Association

Advertisement